In this study, we identify a novel DNA methylation episignature as a sensitive diagnostic biomarker for NEDAUS, a neurodevelopmental disorder linked to CUL3 haploinsufficiency. The gene discussed is CUL3; the disease is neurodevelopmental disorder with or without autism or seizures.